CD20-targeted immunotherapies in B-cell malignancies: mechanistic and clinical advances. Hasani R, Pourseif MM, Alizadeh E, Tohidkia MR, et al. Exp Hematol 2026;160:105444.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hasani R, Pourseif MM, Alizadeh E, Tohidkia MR, et al. CD20-targeted immunotherapies in B-cell malignancies: mechanistic and clinical advances. Exp Hematol 2026;160:105444.
PMID: 42140572